GFAP and Alzheimer disease: In the pursuit of an early biomarker for AD, upregulation of IL-1β in microglia and the additional presence of inflammatory astrocytes, as determined by GFAP and C3 colocalization, was found in retinal tissue from AD patients, indicating that the inflammatory activation of astrocytes is a feature of early AD pathology (Grimaldi et al., 2019).